Delivery Order SPE2DR25D1205-SPE2DR26F0YX0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,075.62 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Injectafer is an intravenous iron replacement therapy used in the treatment of iron...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $10,913.07. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract was executed with an ultimate completion date of December 24, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Injectafer is an iron...
- The Defense Logistics Agency awarded a delivery order valued at $11,318.85 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $9,850.87 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This competitively awarded, firm fixed price delivery order was executed on December 22, 2025, with an ultimate completion date of December 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation, indicating the award was made through open...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials with a ceiling value of $12,323.51. The contract is non-competitive, firm fixed price delivery order awarded on November 20, 2025, with an ultimate completion date of November 21, 2025. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $7,304.98 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on November 14, 2025, with completion scheduled for November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $15,003.41 firm fixed-price delivery order on August 5, 2025, for the supply of Injectafer 750 mg/15 mL vials. The contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $13,079.20. This competitively awarded, firm fixed-price contract is classified as a child order and represents a non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order has an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials, with a ceiling value of $13,146.03. This non-competitive, firm fixed-price delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025. The place of performance is AmerisourceBergen Drug Corp's corporate office in Conshohocken, Pennsylvania. This award is executed under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $14,143.49 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Injectafer 750 mg/15 mL vials. This firm fixed-price, non-set-aside contract is scheduled for completion by June 3, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0YX0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Injectafer 750 mg/15 mL vials with a ceiling value of $1,260.17. The contract, designated as a firm fixed-price delivery order with an ultimate completion date of December 24, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal healthcare system and holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, from which this delivery order is issued. Injectafer is an iron replacement therapy used in the treatment of iron deficiency anemia and falls within AmerisourceBergen's comprehensive portfolio of pharmaceutical products supplied to military and federal healthcare systems. This delivery order exemplifies the company's role as a critical vendor within the DLA Medical Supply Chain, providing timely access to specialty medications and injectable pharmaceuticals that support military health readiness and veteran care. The award underscores AmerisourceBergen's established capability to fulfill federal procurement requirements efficiently through its prime vendor network serving the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/22/25 |